Financials Lunit Inc.

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
56,800 KRW +1.07% Intraday chart for Lunit Inc. +8.60% -30.65%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 364,383 2,332,210 1,633,557 -
Enterprise Value (EV) 2 364.4 2,332 1,464 1,454
P/E ratio -7.95 x - - -
Yield - - - -
Capitalization / Revenue - 93 x 30.5 x 16.9 x
EV / Revenue - 93 x 27.3 x 15.1 x
EV / EBITDA - -60.7 x -111 x 61.7 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - 7.63 x 7.21 x
Nbr of stocks (in thousands) 24,455 28,476 28,760 -
Reference price 3 14,900 81,900 56,800 56,800
Announcement Date 3/21/23 2/15/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 25.08 53.55 96.38
EBITDA 1 - -38.44 -13.15 23.55
EBIT 1 - -42.18 -15.22 22.9
Operating Margin - -168.19% -28.42% 23.77%
Earnings before Tax (EBT) - - - -
Net income 1 -39.12 -36.75 -15.73 12.2
Net margin - -146.52% -29.38% 12.66%
EPS -1,874 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 3/21/23 2/15/24 - -
1KRW in Billions2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2
Net sales 1 - 5.445
EBITDA - -
EBIT 1 - -10.04
Operating Margin - -184.46%
Earnings before Tax (EBT) 1 - -9.996
Net income 1 -2.086 -9.996
Net margin - -183.56%
EPS -85.00 -
Dividend per Share - -
Announcement Date 5/10/23 8/11/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - - -
Net Cash position 1 - - 170 180
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - -24.2% -7.1% 5.55%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - - 7,448 7,873
Cash Flow per Share 2 - - -476.0 448.0
Capex - - - -
Capex / Sales - - - -
Announcement Date 3/21/23 2/15/24 - -
1KRW in Billions2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
56,800 KRW
Average target price
100,000 KRW
Spread / Average Target
+76.06%
Consensus

Annual profits - Rate of surprise